News

Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA

Dr. Glezer’s appointment as Managing Director will strengthen Outcome’s healthcare innovation and product launch expertise. BOSTON–Outcome Capital, LLC, a highly specialized life sciences and healthcare...

Read More
News

Outcome Capital Expands Its Medical Device and Life Science Services Practices with the Addition of Industry Veteran Peter F. Meyer, Ph.D.

BOSTON–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Peter F. Meyer, Ph.D. has been appointed as...

Read More
News

Outcome Capital is happy to announce recent promotions of Thomas Busby, Nick Frame, Mike Casasanta & Carey Gallant

Please join us in congratulating them on their new roles.

Read More
News

Outcome Capital has won honors as the Top Life Sciences Advisory & Investment Banking Firm – 2024 per Life Sciences Magazine

Outcome Capital has won honors as the Top Life Sciences Advisory & Investment Banking Firm – 2024 per Life Sciences Magazine January 2024   Read...

Read More
News

Outcome Capital Promotes Thomas Busby to Director to Expand Medical Device and Life Science Services Practices

BOSTON — Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Thomas F. Busby has been promoted...

Read More
News

Outcome Capital Announces Acquisition of Propella Therapeutics, Portfolio Company of Peterson Companies, by Astellas Pharma

Outcome Capital is a strategic advisor to Peterson Companies, majority shareholder of Propella Boston – December 28, 2023 — Outcome Capital, a highly specialized life sciences...

Read More
News

Outcome Capital Announces Electronic Registry Systems (ERS) Acquisition by Health Catalyst

Boston – November 8, 2023 Outcome Capital, a specialized life science advisory and investment banking firm, today announced that Electronic Registry Systems, Inc. (ERS), a...

Read More
News

Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has entered into...

Read More
News

Outcome Capital and YAFO Capital Announce Strategic Partnership to Expand Global Strategic and Financial Services to Biopharma and Healthcare Clients

The collaboration will allow the partners to globally expand financial advisory services and cross-border transactions for life sciences and biopharmaceutical client companies Boston & Shanghai...

Read More
News

Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review

Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review July 20, 2023 Read the full article here:

Read More
News

Outcome Capital and Jumpstart Enter into a Corporate Partnership to Support Early Education in Underserved Communities

Collaboration will support early childhood education programs and address early childhood teacher retention. July 13, 2023 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a...

Read More
News

Outcome Capital Named Top 10 M&A Consulting Firms In 2022

Outcome Capital Named Top 10 M&A Consulting Firms December 1, 2022 Outcome Capital leads in Financial Services Review annual listing of 10 companies that are...

Read More
News

Outcome Capital Advises ELIOS Vision on Growth Financing Round

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing...

Read More
News

Outcome Capital Advises NanoHive Medical on Growth Financing Round

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that NanoHive Medical, LLC closed on an oversubscribed...

Read More
News

Outcome Capital Announces Innara Health and Cardinal Health Partner to Advance Neonatal Development

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Innara Health and Cardinal Health have partnered...

Read More
News

Outcome Capital Expands Its HealthTech and Digital Health Practice with the Addition of Karl Hess as Managing Director

March 28, 2022 10:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced...

Read More
News

Outcome Capital Congratulates Dr. Michaele Esdale on Her Invitation to Join the Business Journals Leadership Trust

The Business Journals Leadership Trust announced yesterday that Dr. Michaele Esdale, Vice President of Finance and Operations at Outcome Capital, has joined its exclusive, invitation-only...

Read More
News

Outcome Capital Announces Getinge Has Acquired Verrix

November 12, 2021 10:48 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized life sciences and healthcare advisory and investment banking firm, today announced that...

Read More
News

MedTech Money Podcast – Investment Banker’s Insight

  Podcast Available At: Spotify Apple Podcasts Google Podcasts Overview: Thomas Busby, Vice President at Outcome Capital, joins host, Giovanni Lauricella, to discuss what an...

Read More
News

Outcome Capital Advises Nova Technologies in its transaction with Slate Capital Group

June 23, 2021, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in aerospace, defense and government services, technology, and...

Read More

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278